Local view for "http://purl.org/linkedpolitics/eu/plenary/2000-10-26-Speech-4-087"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20001026.2.4-087"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Adopting a resolution on a Community strategy on endocrine disrupters is the minimum we should do on a complex subject for which no regulation exists. Listing and studying the phenomenon of disruption of the endocrine systems of men and animals, validating the studies, and demonstrating the causal links between certain products and certain anomalies found in humans and animals (decline in fertility, certain malformations, certain cancers), is a necessary point of departure as long as it respects the precautionary principle and at the same time promotes a need for transparency totally absent from the text.
The fact is that private and public decision-makers will not act unless obliged to do so by public opinion. The lists of products suspected of being endocrine disrupters must be made known to the public and health professionals, as and when new ones are discovered.
While studies must be conducted to find out about the dangers of endocrine disrupters, firms using suspect products must also be made subject to regulations applicable to drugs, especially in terms of furnishing proof that these products are harmless, whenever they are considered suspect by the European groups of experts.
So an arsenal of restrictive regulations is urgently needed to make it possible to ban such products in the years ahead."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples